Hints and tips:
Related Special Reports
...But as the Thanksgiving deadline approached, lawyers said they were dealing with an “avalanche” of last-minute claims, the vast majority of which had been brought by former inmates against New York prisons...
...Contributions from the company’s acquisitions — notably the $43bn purchase of cancer biotechnology company Seagen — have yet to move the needle....
...The lack of deals and an avalanche of money that has poured into credit markets is beginning to relieve headaches across the private equity world....
...But Amyris had also branched out into being an incubator for beauty start-ups including Rose Inc, Costa Brazil and JVN hair care, and it proved too huge a leap from developing molecules to developing brands...
...I have days where I wonder if my sober love for wine is idiotic and reckless, a cartoon character skiing down an avalanche-prone mountain, but then I remember something the late Lou Reed said to me at the...
...The Romans gave us underfloor heating and the oculus; we offer crumbling concrete, microplastics and an avalanche of Nespresso pods....
...A version of this article was first published by Nikkei Asia on January 26. ©2024 Nikkei Inc. All rights reserved....
...Nasdaq’s lower listing fees and costs mean many smaller companies choose to float there, including capital-hungry biotechnology groups which frequently tap the market for funds — generating fees for their...
...The Federal Trade Commission sued to block the biotechnology company Amgen’s $28.3bn deal to acquire Horizon Therapeutics, Italy is struggling to spend €200bn in EU Covid recovery funds, and Ukraine said...
...Daina Graybosch, analyst at SVB Leerink, citing Paxlovid, Gilead Sciences’ remdesivir — an antiviral administered via injection — and monoclonal antibody therapy sotrovimab from GlaxoSmithKline and Vir Biotechnology...
...Pfizer is putting its Covid-19 windfall to work by splashing out $43bn to buy cancer biotechnology company Seagen....
...A version of this article was first published by Nikkei Asia on August 3. ©2023 Nikkei Inc. All rights reserved....
...One of the most interesting is WireScreen, part of The Wire Digital Inc, a US-based news and data platform focused on China and global supply chains....
...A cancer-focused biotechnology company has sued eight of the US’s largest market-making traders including Citadel Securities, Susquehanna and Virtu, alleging that they deliberately drove down its share price...
...The avalanche of launches has come despite an embarrassing lack of traction for many early offerings in the metaverse — a futuristic immersive version of the internet enabled by virtual and augmented reality...
...of emails seen by the FT and released by the non-profit transparency collective Distributed Denial of Secrets, it was a secret, multiyear legal campaign co-ordinated by CLS to help Prigozhin overcome an avalanche...
...A Tesla stock price slide that began in the autumn turned into an avalanche; shares are now 73 per cent below their peak of a little more than a year ago. Musk himself is $200bn poorer....
...On paper, Merck’s interest in buying the cancer biotechnology company SeaGen for about $40bn makes plenty of sense. The US drugmaker is flush with cash — to the tune of $8.6bn at the end of March....
...Merck & Co is in talks to buy the cancer biotechnology company SeaGen for about $40bn, according to two people familiar with the matter....
...The New York hedge fund has undergone an overhaul after being swept up in an avalanche of high interest rates and tumbling tech stocks....
...The Nasdaq biotechnology index has shed nearly 27 per cent of its value this year. Prior to Tuesday’s deal announcement, Biohaven’s shares had fallen 40 per cent since January....
...Motif was launched by Boston-based biotechnology group Ginkgo Bioworks in 2019, and uses synthetic biology to create products for the plant-based food sector....
...experts said the declining effectiveness of the two most commonly used antibody treatments has led to shortages of a third monoclonal antibody treatment sotrovimab, which is made by GlaxoSmithKline and Vir Biotechnology...
...The US Securities and Exchange Commission said that fast-food giant Yum China, biotechnology groups BeiGene, Zai Lab and HutchMed, and technology company ACM Research faced delisting....
...Merck’s news hit shares in vaccine makers such as Moderna and BioNTech, as well as Vir Biotechnology, developer of a monoclonal antibody therapy in partnership with GlaxoSmithKline....
International Edition